StockDuty ← Dashboard Aug 10, 2026 05:00 PM ET
CatalystFDA/Bio

Artelo Enrolls First Patient In Phase 2 DREAM Trial For ART27.13 In Treating Intralocular Pressure

Artelo Enrolls First Patient In Phase 2 DREAM Trial For ART27.13 In Treating Intralocular Pressure

Sources